Fig. 1From: Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV studySchedule of study assessments. Asterisk assessments at weeks 4, 8, and 16 were done by telephone contact. The current report focuses on data up to week 24 of treatment. BRB brief repeatable battery, HAD hospital anxiety and depression scale, SD1 study day 1, STAI state–trait anxiety inventoryBack to article page